Drug Type Small molecule drug |
Synonyms ARD 501, ARD501 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Aardvark Therapeutics, Inc.Startup |
Active Organization Aardvark Therapeutics, Inc.StartupTulex Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autism Spectrum Disorder | Phase 2 | US | Aardvark Therapeutics, Inc.Startup | 01 Aug 2024 |